Integrated Pre-Formulation and Drug Product Characterization Efforts Leading to Nimble Advancement of Drug Candidates to Human Clinical Trials

Gaauri Naik, currently director at Relay Therapeutics, joined Relay for more than 5 years ago and has led R&D formulation efforts which focused on profiling and formulating early preclinical stage small molecules and then advancing solid oral dosage forms into early clinical development. Prior to Relay, Gaauri has worked at various pharmaceutical/biotech companies. There, she managed and contributed to formulation development and commercial manufacturing that covered early to late-stage development along with technical transfer to commercial manufacturing facilities which included solid oral and parenteral dosage forms. Gaauri developed extensive expertise in technologies for delivering poorly soluble drugs, injectable formulations including novel drug delivery approaches. She has held roles of increasing responsibility at Cubist, Merck, Keryx and Relay Therapeutics., culminating in her role to lead clinical formulation development including pediatric formulation development and commercial drug product manufacturing across North America, Europe and Asia